English  |  正體中文  |  简体中文  |  总笔数 :2853504  
造访人次 :  45192447    在线人数 :  761
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"ferris r l"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 1-4 / 4 (共1页)
1 
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2021-03-09T06:46:02Z A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141 Kiyota N.;Hasegawa Y.;Takahashi S.;Yokota T.;Yen C.-J.;Iwae S.;Shimizu Y.;Ruey-Long Hong;Goto M.;Kang J.-H.;Sum Kenneth Li W.;Ferris R.L.;Gillison M.;Namba Y.;Monga M.;Lynch M.;Tahara M.; Kiyota N.; Hasegawa Y.; Takahashi S.; Yokota T.; Yen C.-J.; Iwae S.; Shimizu Y.; RUEY-LONG HONG; Goto M.; Kang J.-H.; Sum Kenneth Li W.; Ferris R.L.; Gillison M.; Namba Y.; Monga M.; Lynch M.; Tahara M.
臺大學術典藏 2021-03-09T06:46:02Z A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141 Kiyota N.;Hasegawa Y.;Takahashi S.;Yokota T.;Yen C.-J.;Iwae S.;Shimizu Y.;Ruey-Long Hong;Goto M.;Kang J.-H.;Sum Kenneth Li W.;Ferris R.L.;Gillison M.;Namba Y.;Monga M.;Lynch M.;Tahara M.; Kiyota N.; Hasegawa Y.; Takahashi S.; Yokota T.; Yen C.-J.; Iwae S.; Shimizu Y.; RUEY-LONG HONG; Goto M.; Kang J.-H.; Sum Kenneth Li W.; Ferris R.L.; Gillison M.; Namba Y.; Monga M.; Lynch M.; Tahara M.
臺大學術典藏 2021-03-09T06:45:59Z Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141) Yen C.-J.; Kiyota N.; Hanai N.; Takahashi S.; Yokota T.; Iwae S.; Shimizu Y.; RUEY-LONG HONG; Goto M.; Kang J.-H.; Li W.S.K.; Ferris R.L.; Gillison M.; Endo T.; Jayaprakash V.; Tahara M.
國立成功大學 2020 Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141) Yen, C.-J.;Kiyota, N.;Hanai, N.;Takahashi, S.;Yokota, T.;Iwae, S.;Shimizu, Y.;Hong, R.-L.;Goto, M.;Kang, J.-H.;Li, W.S.K.;Ferris, R.L.;Gillison, M.;Endo, T.;Jayaprakash, V.;Tahara, M.

显示项目 1-4 / 4 (共1页)
1 
每页显示[10|25|50]项目